Advances in understanding of angioimmunoblastic T-cell lymphoma
S Chiba, M Sakata-Yanagimoto - Leukemia, 2020 - nature.com
It has been nearly half a century since angioimmunoblastic T-cell lymphoma (AITL) was
characterized in the early 1970's. Our understanding of the disease has dramatically …
characterized in the early 1970's. Our understanding of the disease has dramatically …
Peripheral T cell lymphomas: from the bench to the clinic
D Fiore, LV Cappelli, A Broccoli, PL Zinzani… - Nature Reviews …, 2020 - nature.com
Peripheral T cell lymphomas (PTCLs) are a heterogeneous group of orphan neoplasms.
Despite the introduction of anthracycline-based chemotherapy protocols, with or without …
Despite the introduction of anthracycline-based chemotherapy protocols, with or without …
The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee
Since the publication of the Revised European-American Classification of Lymphoid
Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have …
Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have …
Genomic profiling for clinical decision making in lymphoid neoplasms
L De Leval, AA Alizadeh, PL Bergsagel… - Blood, The Journal …, 2022 - ashpublications.org
With the introduction of large-scale molecular profiling methods and high-throughput
sequencing technologies, the genomic features of most lymphoid neoplasms have been …
sequencing technologies, the genomic features of most lymphoid neoplasms have been …
Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study
L Falchi, H Ma, S Klein, JK Lue… - Blood, The Journal …, 2021 - ashpublications.org
Peripheral T-cell lymphomas (PTCLs) are uniquely vulnerable to epigenetic modifiers. We
demonstrated in vitro synergism between histone deacetylase inhibitors and DNA …
demonstrated in vitro synergism between histone deacetylase inhibitors and DNA …
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project
RH Advani, T Skrypets, M Civallero… - Blood, The Journal …, 2021 - ashpublications.org
Angioimmunoblastic T-cell lymphoma (AITL) is a unique subtype of peripheral T-cell
lymphoma (PTCL) with distinct clinicopathologic features and poor prognosis. We performed …
lymphoma (PTCL) with distinct clinicopathologic features and poor prognosis. We performed …
[HTML][HTML] Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome
L Veloza, D Cavalieri, E Missiaglia… - …, 2023 - ncbi.nlm.nih.gov
Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare aggressive T-cell
lymphoma most reported in Asia. We performed a comprehensive clinical, pathological and …
lymphoma most reported in Asia. We performed a comprehensive clinical, pathological and …
Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma
P Zhang, M Zhang - Clinical epigenetics, 2020 - Springer
Peripheral T-cell lymphoma (PTCL) is a rare and heterogeneous group of clinically
aggressive diseases associated with poor prognosis. Except for ALK+ anaplastic large-cell …
aggressive diseases associated with poor prognosis. Except for ALK+ anaplastic large-cell …
Classification and diagnostic evaluation of nodal T-and NK-cell lymphomas
AL Feldman, C Laurent, M Narbaitz, S Nakamura… - Virchows Archiv, 2023 - Springer
Nodal T-and NK-cell lymphomas are among the most frequent T-cell malignancies and most
subtypes have aggressive clinical behavior. Evolving understanding of the biology and …
subtypes have aggressive clinical behavior. Evolving understanding of the biology and …
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma
F Lemonnier, V Safar, A Beldi-Ferchiou… - Blood …, 2021 - ashpublications.org
Angioimmunoblastic T-cell lymphoma (AITL) is a frequent T-cell lymphoma in the elderly
population that has a poor prognosis when treated with cyclophosphamide, doxorubicin …
population that has a poor prognosis when treated with cyclophosphamide, doxorubicin …